Here are relevant reports on : last-mile-delivery-market
-
Route Optimization Software Market by Component (Software & Services), Vertical (On-Demand Food Delivery, Ride Hailing & Taxi Services, Field Services, and Retail & FMCG), Organization Size, Deployment Type, and Region - Global Forecast to 2023
The route optimization software market size is expected to grow from to grow from USD 2.95 billion in 2018 to USD 5.07 billion by 2023, at a CAGR of 11.4% from 2018 to 2023. The major drivers of the route optimization software market include the increasing use of logistics-specific solutions and declining hardware and connectivity costs. Some of the major route optimization software vendors include ALK Technologies (US), AMCS (Ireland), Caliper (US), Descartes (Canada), Esri (US), FLS (Germany), Geoconcept (France), Google (US), Portatour (Austria), Llamasoft (US), Maxoptra (UK), Microlise (UK), Omnitracs (US), Optimoroute (US), ORTEC (Netherlands), Paragon Software (UK), PTV Group (Germany), Quintiq (Netherlands), FarEye (India), Route4me (US), RouteSolutions (US), Routific (Canada), Scientific Logistics (US), Truckstops (UK), Verizon Connect (US), and Workwave (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Global Albumin Market, by Product (Human Serum Albumin, Bovine Albumin, Recombinant Serum Albumin) by Application (Therapeutic, Drug Delivery, Culture Media, Vaccine Ingredient) by Region - Forecast to 2022
The global albumin market is projected to grow at a CAGR of around 6% during the forecast period (2017-2022). Factors such as the high demand of albumin in R&D activities, rising non-therapeutic application of albumin, development of plant based albumin, rising production of immunoglobulins, and rise in plasma collection are driving the market. However, the stringent regulations, limited reimbursement, and irrational uses and adverse effects associated with albumin are the factors restraining the growth of this market.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Referral Management Market by Component (Software (Integrated, Standalone), Services), Delivery Mode (Cloud Based, On Premise), Type (Inbound, Outbound), End User (Providers, Payers) – Analysis & Global Forecasts to 2027
The global referral management market growth is primed to transition from USD 3.2 billion in 2022 to USD 6.1 billion by 2027, showcasing a strong CAGR of 13.6%. Growth in the referral management market can be attributed to factors such as technological advancements in healthcare facilitiesand risingadoption of referral management solutions by healthcare providers to offer better care delivery.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
US Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer, Obesity), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), End Users (Hospital, Home Care) - Forecast to 2031
The US injectable drug delivery market, valued at US$285.81 billion in 2025, stood at US$309.90 billion in 2026 and is projected to advance at a resilient CAGR of 8.5% from 2026 to 2031, culminating in a forecasted valuation of US$465.15 billion by the end of the period. The growth of the veterinary contract manufacturing & research market is driven by the increasing adoption of biologics and long-acting injectables, rising demand for patient-centric and self-administration delivery systems, and the need for advanced formulation, device engineering, and scalable manufacturing capabilities.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024
The electronic drug delivery system market is expected to grow from USD 7.8 billion in 2019 to USD 11.9 billion by 2024, at a compound annual growth rate (CAGR) of 8.7%. during the forecast period.The prominent players in the electronic drug delivery systems market are Insulet Corporation (US), Bayer AG (Germany), Medtronic (Ireland), Novo Nordisk A/S (Denmark), Companion Medical (US), F.Hoffmann-La Roche Ltd (Switzerland), United Therapeutics Corporation (US), AstraZeneca (UK), Tandem Diabetes Care (US), Merck Group (Germany), and Amgen (US).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
Cough Assisted Devices Market by product (Automatic Cough Assist Device, Manual Cough Assist Device), Choice of Delivery (Face Mask, Mouth Piece, Adopter), and End User (Hospitals, Homecare Settings) - Global Forecast to 2023
The global cough assist device market is expected to reach USD 226.5 million by 2023 from USD 150.6 million in 2018, growing at a CAGR of 8.5%. Increasing prevalence of chronic obstructive pulmonary disease (COPD) is the major factor that support the growth of the market. In addition to this, changing lifestyle such as smoking; and rising air pollution are the risk factors that support the growth of the cough assist devices during forecast period. On the other hand, rising awareness regarding advanced treatment method among patient population support the growth of the market. However, availability of alternative treatments is expected to hinder the market to a certain extent.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Transdermal Drug Delivery System Market by Type (Patches and Semisolid formulations), Applications (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases), End User, and Region - Global Forecast to 2023
The transdermal drug delivery system market is projected to reach USD 7.1 billion by 2023, growing at a CAGR of 4.5%. The growth of this market is primarily driven by factors such as the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems. The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).
- Published: January 2019
- Price: $ 4950
- TOC Available:
-
Bioresorbable Polymers Market by Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic acid (PLGA), Polycaprolactone) PCL), Application (Orthopedic Devices, Drug Delivery), and Region - Global Forecast to 2029
The bioresorbable polymers market is expected to grow from USD 500.0 million in 2024 to USD 867.2 million by 2029, at a CAGR of 11.6% during the forecast period. The key players profiled in the report include Corbion (Netherlands), Evonik Industries AG (Germany), Foster Corporation (US), KLS Martin Group (Germany), DSM Biomedical (US), Ashland Global Holdings Inc. (US), Zeus Company LLC (US), Seqens (France), Reva Medical, LLC (US), and Poly-Med Incorporated (US).
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Application Testing Services Market by Service Type (Professional, Managed), Testing Type (Functionality, Security, Automation), Delivery Model (Onshore, Offshore), Organization Size, Vertical, and Region - Global Forecast to 2022
The application testing services market was valued at USD 23.69 Billion in 2016 and is projected to reach USD 50.14 Billion by 2022, at a CAGR of 13.5% from 2017 to 2022. The base year considered for the study is 2016. The report provides a detailed overview of the competitive landscape of market players, which presents information with respect to the positioning of 25 key vendors offering application testing services, based on their product offerings and business strategies. Key players operating in the application testing services market include Wipro (India), Cognizant (US), TCS (India), Accenture (Ireland), Capgemini (France), IBM (US), and Infosys (India).
- Published: October 2017
- Price: $ 4950
- TOC Available:
-
Asia Pacific Injectable Drug Delivery Market by Product (Device, Autoinjectors, Formulation, Suspensions, Nanoparticles), Site of Administration (Dermal, Organ), Formulation Packaging (Ampoules, Vials), Usage Pattern (Curative, Immunization) - Forecast to 2031
The Asia Pacific injectable drug delivery market, valued at US$161.32 billion in 2025, stood at US$176.96 billion in 2026 and is projected to advance at a resilient CAGR of 9.8% from 2026 to 2031, culminating in a forecasted valuation of US$282.22 billion by the end of the period. The growth of the Asia Pacific injectable drug delivery market is driven by the increasing incorporation of biologics, biosimilars, and long-acting injectables, alongside a rapidly growing patient population and an escalating burden of chronic diseases across major countries in the region.
- Published: September 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
